Key Takeaways
- Difficult quarter, supply-driven: Boron business was disrupted by a distributor change that stretched lead times from days to 90–100 days, while European exports of ~INR 40 crores practically disappeared.
- Recovery has a date: Boron operations are expected to normalize from the second half of Q3, giving a concrete near-term catalyst.
- Specialty capacity sits idle: The higher-margin specialty business is running at or slightly below 50% utilization, so any demand recovery or new market entry drops through at high incremental margins.
- Tariff fears did not materialize: Not a single existing customer has refused product because of the new U.S. tariffs, and buying patterns have continued as usual.
- What to watch next quarter: Whether boron shipments actually normalize on the stated timeline, the pace of European export replacement in Latin America and the Far East, and any pricing disruption as the Kutch smelter scales up.
Boron Business Disruption
- Root cause: The main supplier of boron raw materials changed its distributor. The previous distributor held stock in India, giving DMCC a lead time of a couple of days. The new distributor operates ex-Turkey, requires advance payment before shipment, and took until April to set up its organization, stretching lead times to nearly 90–100 days.
- Operational impact: Delayed shipments meant DMCC had sufficient material to operate the plant at capacity only by November, well into Q3. The boron business is expected to return to normal operations from the second half of Q3.
- Supply chain concentration: Management stated it is not practical to diversify the boron supply chain because the current source is by far the most economical, and direct contact with the manufacturer is not possible given their structure. The company must optimize within the existing framework.
- Working capital: The new terms, requiring advance payment before shipment, plus rising raw material prices, will increase working capital needs. Management has already arranged support from bankers.
Goculdas: "It is not practical to say that we will be able to diversify the supply chain for boron because what we have is the best and It is something which we need to optimize within the existing framework."
European Export Decline & Market Diversification
- Europe exports collapsed: Exports to Europe of about INR 40 crores have practically disappeared, driven not by competition but by reduced consumption in Europe stemming from internal issues including energy policy and plant shutdowns.
- Replacement underway: DMCC has made a reasonably good start in replacing the specialty chemical business of Europe with other geographies, specifically Latin American and Far East markets, though entering new markets takes time.
- Structural view on Europe: Management believes the European chemical industry will not revive under current energy and industrial policy. Big companies may set up plants elsewhere, but manufacturing in Europe will be very difficult.
- China opportunity: As Chinese producers move downstream, DMCC sees opportunities to enter specialty chemical markets with low-volume products. Exploration started earlier this year and management believes there are good opportunities.
Goculdas: "So, honestly, until they change their energy policy and industrial policy, in my personal opinion, I do not think the European chemical industry will revive in Europe."
U.S. Tariffs
- No customer attrition: Not a single existing customer has refused product from DMCC because of the new U.S. tariffs, and they have continued buying as usual.
- Hoping for resolution: Management expressed hope that a good trade deal will be signed in days to come, ending all acrimony.
Goculdas: "not a single existing customer has refused product from us because of the new tariffs. So, they have continued buying as usual and it is a positive thing."
Capacity & Product Portfolio
- Utilization split: Commodity business is running at 95–100% capacity. Specialty business, where higher-margin products sit, is at or slightly below 50%, leaving significant operating leverage if demand returns or new markets are created.
- No new products yet: The company has not added any new products but is working on process development and expanding applications within existing chemistry areas, such as different types of thiophenols and newer specialty borates. Specific products will not be disclosed until at a different commercial stage for confidentiality reasons.
- Commercialization strategy: Management is looking at products similar to existing ones so they can quickly commercialize if demand fructifies, though customer approval time is out of their control.
Kutch Smelter & Sulfur Costs
- Sulfur cost pass-through: Sulfur costs have gone up for all consumers as the Kutch smelter has started operations. DMCC has been able to pass on the price increase to customers so far, meaning top line growth is price growth, not volume growth.
- Domestic market buffer: The main end use of sulfuric acid is fertilizers, and government policy is to increase domestic production, so the domestic market is also growing. Management describes the current position as stable from the market side.
- Disruption caution: Management continues to caution that as the Kutch smelter fully scales up, it will put a large quantity of material into the market which is bound to disrupt pricing. The timing and extent of this disruption are unknown.
Cost & Capex Initiatives
- Solar power plant commissioned: The plant was commissioned at the end of Q2 at Roha, with the full effect to be seen from the current quarter onwards. It is expected to reduce electricity cost and carbon footprint, covering more than 80% of Roha's requirement through renewables.
- Capex posture: Only incremental capex is planned, about INR 10 crores approved for this year and a similar level next year unless other projects arise. The idea is not to do any large capex at this time, using existing cash flows and some borrowings for incremental projects.
- Capital allocation: No buyback or corporate action is currently being considered. Cash flows after capex spend will be used to reduce term loans.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Boron business normalization | Boron operations return to normal, plant running at capacity | Second half of Q3 FY26 |
| Solar power cost reduction | Full effect of solar plant on electricity cost and carbon footprint | Current quarter (Q3) onwards |
| Capex | Incremental capex of ~INR 10 crores | FY26, similar level FY27 |
| European export replacement | Replace lost ~INR 40 crores of European exports via Latin America and Far East markets | No timeline given; "takes time" |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹126 cr, flat QoQ and +25% YoY |
| H1 FY26 revenue | ₹250 cr, vs ₹188 cr in H1 FY25 |
| Profit before tax | ₹8.28 cr, vs ₹11 cr in Q1 FY26 and ₹8.6 cr in Q2 FY25 |
| H1 FY26 profit before tax | ₹19 cr, vs ₹10.4 cr in H1 FY25 |
| Boron business revenue loss | ~₹10 cr per month of top line lost due to raw material supply disruption |
| Exports to Europe | ~₹40 cr annually, has practically disappeared |
| Commodity chemicals capacity utilization | 95% to 100% |
| Specialty chemicals capacity utilization | ~50% or slightly below |
| Renewable energy coverage at Roha | >80% of requirement covered by renewables |
| FY26 CAPEX approved | ~₹10 cr, similar level expected next year |
| Boron business normalization | Expected from second half of Q3 FY26 |